# Sensitivity and Specificity of the Modified Helicobacter Test INFAI

> **NCT04294823** · — · WITHDRAWN · sponsor: **International Pharmaceutical Consultancy**

## Conditions studied

- Dyspepsia
- GERD

## Interventions

- **DIAGNOSTIC_TEST:** Helicobacter Pylori Diagnostic
- **DEVICE:** Vital signs measurments
- **DIAGNOSTIC_TEST:** endoscopy
- **DRUG:** Nexium Pill

## Key facts

- **NCT ID:** NCT04294823
- **Lead sponsor:** International Pharmaceutical Consultancy
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-11
- **Primary completion:** 2021-01
- **Final completion:** 2021-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Administrative delays were too long
- **Last updated:** 2021-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04294823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04294823, "Sensitivity and Specificity of the Modified Helicobacter Test INFAI". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04294823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*